{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T02:19:05Z","timestamp":1773973145368,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalradiologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Radiology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.crad.2026.107272","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T07:40:49Z","timestamp":1769758849000},"page":"107272","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The value of 18F-fluorodeoxyglucose positron emission tomography\/computed tomography in the diagnosis and evaluation of TAFRO syndrome: a review of cases and literature"],"prefix":"10.1016","volume":"95","author":[{"given":"H.","family":"Xian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.crad.2026.107272_bib1","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/s12185-016-1979-1","article-title":"Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome. 2015 version","volume":"103","author":"Masaki","year":"2016","journal-title":"Int J Hematol"},{"key":"10.1016\/j.crad.2026.107272_bib2","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/ajh.26292","article-title":"Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multicentric Castleman disease","volume":"96","author":"Nishimura","year":"2021","journal-title":"Am J Hematol"},{"key":"10.1016\/j.crad.2026.107272_bib3","first-page":"320","article-title":"[Thrombocytopenia with mild bone marrow fibrosis accompanied by fever, pleural effusion, ascites and hepatosplenomegaly]","volume":"51","author":"Takai","year":"2010","journal-title":"Rinsho Ketsueki"},{"key":"10.1016\/j.crad.2026.107272_bib4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.hoc.2017.09.009","article-title":"TAFRO syndrome","volume":"32","author":"Igawa","year":"2018","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.crad.2026.107272_bib5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/biomedicines12051070","article-title":"Tacrolimus treatment for TAFRO syndrome","volume":"12","author":"Shirai","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.crad.2026.107272_bib6","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.2169\/internalmedicine.8522-16","article-title":"Successful treatment of TAFRO syndrome with Tocilizumab, prednisone, and cyclophosphamide","volume":"56","author":"Kikuchi","year":"2017","journal-title":"Intern Med"},{"key":"10.1016\/j.crad.2026.107272_bib7","doi-asserted-by":"crossref","first-page":"564","DOI":"10.3109\/14397595.2015.1120389","article-title":"TAFRO syndrome successfully treated with tocilizumab: a case report and systematic review","volume":"28","author":"Sakai","year":"2018","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.crad.2026.107272_bib8","doi-asserted-by":"crossref","first-page":"168","DOI":"10.4103\/ijn.IJN_520_20","article-title":"TAFRO syndrome treated effectively with corticosteroids: a case report and review of the literature","volume":"32","author":"Sozel","year":"2022","journal-title":"Indian J Nephrol"},{"key":"10.1016\/j.crad.2026.107272_bib9","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s12308-017-0288-9","article-title":"TAFRO syndrome with a rapid fatal course despite corticosteroid and tocilizumab therapy","volume":"9","author":"Tanaka","year":"2016","journal-title":"J Hematop"},{"key":"10.1016\/j.crad.2026.107272_bib10","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.2169\/internalmedicine.8360-16","article-title":"Tocilizumab-resistant TAFRO syndrome complicated by type II respiratory failure","volume":"56","author":"Aoki","year":"2017","journal-title":"Intern Med"},{"issue":"27","key":"10.1016\/j.crad.2026.107272_bib11","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.crad.2026.107272_bib12","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/1097-0142(195607\/08)9:4<822::AID-CNCR2820090430>3.0.CO;2-4","article-title":"Localized mediastinal lymphnode hyperplasia resembling thymoma","volume":"9","author":"Castleman","year":"1956","journal-title":"Cancer"},{"key":"10.1016\/j.crad.2026.107272_bib13","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1159\/000526640","article-title":"Recent advances in castleman disease","volume":"45","author":"Hoffmann","year":"2022","journal-title":"Oncol Res Treat"},{"key":"10.1016\/j.crad.2026.107272_bib14","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.4103\/0366-6999.237399","article-title":"TAFRO Syndrome-A specific subtype of Castleman's disease in China","volume":"131","author":"Ma","year":"2018","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.crad.2026.107272_bib15","doi-asserted-by":"crossref","unstructured":"Jaafari A., Taheri N., Mansour S., et al. TAFRO syndrome on 18F-FDG-PET\/CT: an appealing diagnostic tool. Diagnostics (Basel, Switzerland), 14(10), 1025. https:\/\/doi.org\/10.3390\/diagnostics14101025.","DOI":"10.3390\/diagnostics14101025"},{"key":"10.1016\/j.crad.2026.107272_bib16","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/RLU.0000000000002278","article-title":"FDG PET\/CT findings in TAFRO syndrome","volume":"43","author":"Hotta","year":"2018","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.crad.2026.107272_bib17","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/ajh.24242","article-title":"Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease","volume":"91","author":"Iwaki","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.crad.2026.107272_bib18","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1007\/s00277-020-04275-0","article-title":"Tocilizumab for the treatment of TAFRO syndrome: a systematic literature review","volume":"99","author":"Akiyama","year":"2020","journal-title":"Ann Hematol"},{"key":"10.1016\/j.crad.2026.107272_bib19","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1007\/s00117-004-1121-x","article-title":"PET-CT bei Lymphompatienten [PET\/CT in lymphoma patients]","volume":"44","author":"Steinert","year":"2004","journal-title":"Radiologe"},{"key":"10.1016\/j.crad.2026.107272_bib20","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.5588\/ijtld.12.0010","article-title":"(18)F-FDG PET\/CT in tuberculosis: an early non-invasive marker of therapeutic response","volume":"16","author":"Martinez","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.crad.2026.107272_bib21","first-page":"42","article-title":"(18)F-FDG PET\/CT imaging in systemic lupus erythematosus related autoimmune haemolytic anaemia and lymphadenopathy","volume":"19","author":"Zhang","year":"2016","journal-title":"Hell J Nucl Med"},{"key":"10.1016\/j.crad.2026.107272_bib22","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.2967\/jnumed.115.160507","article-title":"Characterizing POEMS syndrome with 18F-FDG PET\/CT","volume":"56","author":"Pan","year":"2015","journal-title":"J Nucl Med"}],"container-title":["Clinical Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926026000486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926026000486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T01:36:08Z","timestamp":1773970568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009926026000486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":22,"alternative-id":["S0009926026000486"],"URL":"https:\/\/doi.org\/10.1016\/j.crad.2026.107272","relation":{},"ISSN":["0009-9260"],"issn-type":[{"value":"0009-9260","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The value of 18F-fluorodeoxyglucose positron emission tomography\/computed tomography in the diagnosis and evaluation of TAFRO syndrome: a review of cases and literature","name":"articletitle","label":"Article Title"},{"value":"Clinical Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crad.2026.107272","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Royal College of Radiologists. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107272"}}